These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34494075)

  • 21. Hepatitis C prevalence--a nationwide serosurvey.
    Amin J; Gidding H; Gilbert G; Backhouse J; Kaldor J; Dore G; Burgess M
    Commun Dis Intell Q Rep; 2004; 28(4):517-21. PubMed ID: 15745402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners.
    Marukutira T; Barter R; Moore KP; Hellard ME; Richmond J; Turner K; Pedrana AE; Melody S; Johnston FH; Owen L; Boom WVD; Scott N; Thompson A; Iser DM; Spelman T; Veitch M; Stoové M; Doyle JS
    Int J Drug Policy; 2023 Nov; 121():104184. PubMed ID: 37714008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
    Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
    Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
    Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Sussing that doctor out.' Experiences and perspectives of people affected by hepatitis C regarding engagement with private general practitioners in South Australia: a qualitative study.
    Scarborough J; Miller ER; Aylward P; Eliott J
    BMC Fam Pract; 2017 Nov; 18(1):97. PubMed ID: 29187145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients.
    Mandel E; Biondi MJ; Mendlowitz A; Maheandiran M; Hollingdrake E; Vanderhoff A; Wolfson-Stofko B; Capraru C; Feld JJ; Logan R
    J Clin Psychiatry; 2023 Jul; 84(5):. PubMed ID: 37530609
    [No Abstract]   [Full Text] [Related]  

  • 28. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
    Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D;
    MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in Australia.
    Butler K; Day C; Sutherland R; van Buskirk J; Breen C; Burns L; Larney S
    Int J Drug Policy; 2017 Sep; 47():102-106. PubMed ID: 28789820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public health surveillance of hepatitis C: can it identify incident cases?
    Staff MP; Brnabic AJ; Schwarz J; Holt DA
    Aust N Z J Public Health; 2000 Apr; 24(2):198-200. PubMed ID: 10790941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study.
    Alavi M; Law MG; Grebely J; Amin J; Hajarizadeh B; George J; Dore GJ
    J Hepatol; 2016 Nov; 65(5):879-887. PubMed ID: 27401548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.
    Heil J; Soufidi K; Stals F; Frantzen H; Robroek-Schaecken A; Bakker CM; van Nunen AB; Dukers-Muijrers NHTM; Hoebe CJPA
    Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):851-856. PubMed ID: 31688310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving surveillance for acute hepatitis C.
    Deacon RM; Wand H; Stelzer-Braid S; Treloar C; Maher L
    Commun Dis Intell Q Rep; 2011 Mar; 35(1):16-20. PubMed ID: 21698979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort study.
    Iranpour N; Dore GJ; Martinello M; Matthews GV; Grebely J; Hajarizadeh B
    Sex Health; 2020 Jun; 17(3):223-230. PubMed ID: 32223841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot project harnessing surveillance systems to support clinicians providing clinical care for people diagnosed with hepatitis C in Victoria, Australia, September 2021 to 31 March 2022.
    Abbott M; MacLachlan JH; Romero N; Matthews N; Higgins N; Lee A; Stoove M; Marukutira T; Quinn B; Allard NL; Cowie BC
    Euro Surveill; 2024 Jul; 29(29):. PubMed ID: 39027939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis C patients lost in the system: predictive factors of non-referral or loss of follow-up in Hepatology units.
    Del Pino Bellido P; Guerra Veloz MF; Cordero Ruiz P; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Dec; 113(12):833-839. PubMed ID: 33393328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach.
    Li W; Chang TS; Chang SZ; Chen CH; Chen MY
    BMC Infect Dis; 2020 Oct; 20(1):737. PubMed ID: 33028228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients.
    McGibbon E; Bornschlegel K; Balter S
    Am J Med; 2013 Aug; 126(8):718-22. PubMed ID: 23786667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.